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ABSTRACT The mechanism of binding of blood coagulation cofactor factor Va to acidic-lipid-containing membranes has
been addressed. Binding isotherms were generated at room temperature using the change in fluorescence anisotropy of
pyrene-labeled bovine factor V. to detect binding to sonicated membrane vesicles containing either bovine brain phospha-
tidylserine (PS) or 1,2-dioleoyl-3-sn-phosphatidylglycerol (DOPG) in combination with 1 -palmitoyl-2-oleoyl-3-sn-phosphati-
dylcholine (POPC). The composition of the membranes was varied from 0 to 40 mol % for PS/POPC and from 0 to 65 mol
% for DOPG/POPC membranes. Fitting the data to a classical Langmuir adsorption model yielded estimates of the
dissociation constant (Kd) and the stoichiometry of binding. The values of Kd defined in this way displayed a maximum at low
acidic lipid content but were nearly constant at intermediate to high fractions of acidic lipid. Fitting the binding isotherms to
a two-process binding model (nonspecific adsorption in addition to binding of acidic lipids to sites on the protein) suggested
a significant acidic-lipid-independent binding affinity in addition to occupancy of three protein sites that bind PS in preference
to DOPG. Both analyses indicated that interaction of factor Va with an acidic-lipid-containing membrane is much more
complex than those of factor Xa or prothrombin. Furthermore, a change in the conformation of bound pyrene-labeled factor
Va with surface concentration of acidic lipid was implied by variation of both the saturating fluorescence anisotropy and the
binding parameters with the acidic lipid content of the membrane. Finally, the results cannot support the contention that
binding occurs through nonspecific adsorption to a patch or domain of acidic lipids in the membrane. Factor V, is suggested
to associate with membranes by a complex process that includes both acidic-lipid-specific and acidic-lipid-independent sites
and a protein structure change induced by occupancy of acidic-lipid-specific sites on the factor Va molecule.
INTRODUCTION
Factor V is a vitamin-K-independent pro-cofactor of the
coagulation cascade. It circulates in blood plasma as a single
polypeptide chain and is activated by thrombin into a het-
erodimer (factor Va), the two chains of which are derived
from the amino and carboxy terminals of the parent mole-
cule. The two chains are noncovalently associated (Esmon,
1979; Nesheim and Mann, 1979) and may be dissociated in
the presence of divalent metal ion chelators, separated, and
then reassociated to full activity by the addition of divalent
metal ions (Esmon, 1979; Krishnaswamy et al., 1989). The
light chain (mol wt = 74,000; Nesheim and Mann, 1979)
but not the heavy chain (mol wt = 94,000) of factor Va will
bind to acidic phospholipid membranes in the presence or
absence of calcium ions (Bloom et al., 1979; Higgins and
Mann, 1983; van de Waart et al., 1983; Pusey and Nelses-
tuen, 1984). While this work was being prepared for pub-
lication, Rosing et al. (1993) reported that two forms of
factor Va were isolated from human plasma. These were
reported to differ in the molecular weight of their light
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chains (74,000 and 71,000), in their functional properties,
and dramatically in their binding to supported phospholipid
bilayers. We have found similar heterogeneity in bovine
factor Va light chain. However, at the Ca2+ concentrations
used in these studies, we have found these two forms of
factor Va to bind with quite similar affinities (Kd values
within a factor of 2-3) to phosphatidylserine (PS)-contain-
ing small, unilamellar vesicles (SUVs) (Koppaka and Lentz,
in preparation).
The assembled prothrombinase complex is composed of
factor Xa (a serine protease) associated with factor Va on a
negatively charged membrane surface in the presence of
calcium. Factor Xa cleaves its substrate, prothrombin, in two
places to form another serine protease, thrombin. Thrombin,
in addition to cleaving fibrinogen to fibrin, serves as a
central control protease in blood coagulation. Although
factor Xa alone may activate prothrombin in solution, the
assembly of the prothrombinase complex on a membrane
surface accelerates the production of thrombin by approxi-
mately five orders of magnitude (Nesheim et al., 1979;
Rosing et al., 1980). Numerous studies have addressed the
issue of how the interaction between the proteins and mem-
brane of this complex might lead to this rate enhancement
(e.g., Nesheim et al., 1981; Husten et al., 1987; Boscovic et
al., 1990; Walker and Krishnaswamy, 1994). The heavy
chain of factor Va interacts with prothrombin, and this
interaction may help direct the sequence of the two proteo-
lytic cleavages required to activate prothrombin so as to
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optimize the rate of thrombin formation (Esmon et al., 1973;
Guinto and Esmon, 1984).
The phospholipid membrane may be as important as the
protein components of the prothrombinase complex in en-
hancing the activation of prothrombin. It was concluded in
an early study that a negatively charged membrane surface
was required for the production of a clot (Papahadjopoulos
and Hanahan, 1964); however, only the charge and not the
chemical nature of the lipid headgroup was assumed to be
important. More recent studies of the activity of the pro-
thrombinase complex assembled on membranes composed
of different acidic phospholipids showed greater efficiency
of thrombin generation with PS- and phosphatidic-acid-
containing membranes than with phosphatidylglycerol-,
phosphatidylinositol-, and phosphatidylethanolamine-con-
taining membranes (Jones et al., 1985; Pei et al., 1993). In
agreement with our report of PS specificity, even PS-con-
taining membranes with a net positive charge have been
shown to retain procoagulant activity (Rosing et al., 1988),
whereas membranes containing D-PS do not support throm-
bin generation (Comfurius et al., 1994). Consistent with this
picture, we have observed that prothrombin undergoes con-
formational changes when bound to PS-containing but not
to phosphatidylglycerol-containing membranes (Lentz et
al., 1991; Wu and Lentz, 1991) and have noted that these
could explain some of the observed PS-specific rate en-
hancement (Pei et al., 1993). Clearly, an understanding of
the specific interactions between different acidic lipid mem-
branes and the component proteins of the prothrombinase
complex is needed if we are to decipher the specific role of
PS in the functioning of the prothrombinase complex.
In this paper, we report a systematic examination of the
binding of pyrene-labeled factor (pyr-Va) to model mem-
branes composed either of PS/1-palmitoyl-2-oleoyl-3-sn-
phosphatidylcholine (POPC) or of 1,2-dioleoyl-3-sn-phos-
phatidylglycerol (DOPG)/POPC. We have analyzed the
data both in terms of a traditional Langmuir adsorption
model and in terms of a simple, two-process binding model
to describe factor Va interaction with membranes. The re-
sults suggest that factor Va association with an acidic-lipid-
containing membrane is a complex process involving a
significant acidic-lipid-independent membrane interaction,
occupancy of a very few acidic-lipid sites that favor PS over
DOPG, and protein conformational changes associated with
occupancy of these sites.
MATERIALS AND METHODS
Hepes was purchased from Fisher Scientific (Charlotte, NC). POPC,
DOPG, and bovine brain PS were purchased from Avanti Polar Lipids
(Birmingham, AL). The N-(l-pyrene)maleimide adsorbed to Celite (10%)
was from Molecular Probes (Eugene, OR). Polyethyleneglycol, average
molecular weight of 15,000, was purchased from Aldrich Chemical Co.
(Milwaukee, WI). All other chemicals were reagent grade or the best grade
available.
Protein purification
Bovine factor Va was immunopurified and labeled with pyrene maleimide
as described previously (Krishnaswamy and Mann, 1988). Such prepara-
tions typically show a 55-kDa impurity (10-15%) on Coomassie-stained
gels (Odegaard and Mann, 1987). Preparations of the pyr-Va were evalu-
ated by anisotropy measurements followed by competition binding mea-
surements with unlabeled factor Va or unlabeled factor Va light chain
(Krishnaswamy and Mann, 1988), by activity in a clotting assay (Nesheim
et al., 1980), and by sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (Wycoff et al., 1977) using the Bio-Rad (Richmond, CA) Minigel
system. The modified protein was determined to be equivalent to unmod-
ified factor Va by these criteria. The proteins were stored at -70°C as
ammonium sulfate precipitates or in 10 mM Tris, 10 mM borate, 1 mM
CaCl2, 50% glycerol buffer, pH 8.3. In preparation for use, the protein was
resuspended and exchanged into assay buffer (20 mM Hepes, 150 mM
NaCl, 4 mM CaCl2, pH 7.4) in Centricon 10 microconcentrators (Amicon,
Danvers, MA) preadsorbed with polyethylene glycol 15,000.
Protein concentration was determined by absorbance at 280 nm, cor-
rected for solution scattering. The extinction coefficient (E2' '9") used for
factor Va was 1.74; the molecular weight used was 150,000 (Krish-
naswamy and Mann, 1988).
Membrane preparation
Small unilamellar vesicles (SUVs) were prepared by mixing
the appropriate amounts of purified POPC and either PS or
DOPG in chloroform/methanol solution, removing the sol-
vent under a stream of argon, and dissolving the resulting
residue in benzene or cyclohexane. The dissolved lipids
were shell frozen and lyophilized overnight to yield a dry
white powder. The dried lipids were suspended in buffer (20
mM Hepes, 150 mM NaCl, pH 7.4) and probe sonicated to
clarity at 15°C in a Heat Systems Ultrasonics (Farmingdale,
NY) model 350 Sonicator. After sonication, the suspension
was centrifuged at 72,000 rpm for 25 min at 15°C in a
Beckman TLhIO centrifuge (using a TLA100.3 rotor) to
obtain a homogeneous suspension of vesicles (Barenholz et
al., 1977). The size of the SUVs was estimated by quasi-
elastic light scattering (Lentz et al., 1992). All PS/POPC
vesicle preparations contained particles with diameters in
the range of 400-600 A (mean, 540 A), whereas DOPG/
POPC vesicles were slightly smaller (350-550 A; mean,
470 A). Vesicle size distributions showed no clear trend
with lipid composition. POPC concentration was deter-
mined by [14C]dimyristoylphosphatidylcholine (Amersham,
Arlington Heights, IL) incorporated into POPC stocks. To-
tal phosphate concentration in a vesicle sample was deter-
mined using the method of Chen et al. (1956). Comparison
of these two concentrations allowed determination of the
actual phospholipid composition of the final vesicle sample.
In all cases, phospholipid composition, expressed as the
mole percent of acidic phospholipids present, was within
2-3 mol % of the target value, this being also the experi-
mental uncertainty in the reported values.
Generation of fluorescence anisotropy
binding isotherms
Anisotropy measurements were collected on SLM 8000 photon counting
fluorescence spectrophotometers (Krishnaswamy and Mann, 1988). Flu-
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orometers were used in the T format with Glan-Thompson polarizing filters
in the excitation and two emission pathways (Lakowicz, 1983). Excitation
slits were 4 nm, and the excitation wavelength was 330 nm. Long-pass
filters (Shott KV389, Duryea, PA) were placed in the emission path to
reduce the effects of Raman scatter, and a 6-nm bandwidth, 396-nm
bandpass filter (Ealing Optical, South Natick, MA) was used in the mea-
surement emission path. Alternatively, the emission monochromator was
set at 396 nm with 8-nm emission slits. All buffers were filtered through
0.2-,um filters (Costar, Cambridge, MA); protein solutions were mi-
crofuged for 5 min at 4°C to reduce solution scatter. Fluorescence titrations
were performed in a 1 X 1 cm cuvette (initial volume, 2 ml) by adding
aliquots of SUVs in microliter volumes, with subsequent stirring for 1 min,
to a fixed concentration of pyr-Va. Protein and phospholipid concentrations
were corrected continuously for dilution during the titration so as to
accurately reflect actual concentrations in the cuvette. Titrations were
performed at a minimum of two protein concentrations from 0.085 to 0.4
,uM. Previous measurements (Krishnaswamy and Mann, 1988) employed a
comparable concentration range (0.075 to 0.17 ,uM). For the sake of visual
comparison in Fig. 4 of fits of the two-process binding model to experi-
ments performed at different protein concentrations, data at different pro-
tein concentrations were normalized to 0.085 ,uM total pyr-Va, according
to
[Ptotal] [PLtotal
[Ptotal]l [PLtotal]l
Readings (an average of 10 per measurement) were taken approximately 30
s after cessation of stirring by integration of the signal at each position of
the excitation polarizer over 10 s. The resulting fluorescence anisotropy
values increased saturably, and all isotherms were carried out whenever
possible to lipid concentrations at least twofold beyond apparent saturation.
Generation and analysis of duplicate isotherms on different instruments
demonstrated no variation in the data. Corrections were made for fluoro-
phore dilution but were not made for inner-filter effects because the
absorbance of the final titrations was not greater than 0.1 at 280 nm.
Binding parameter analysis: Langmuir
adsorption model
Individual isotherms were evaluated to assign binding parameters accord-
ing to the following expression for the concentration of bound protein
(Krishnaswamy et al., 1986; Koppaka and Lentz, 1996):
[Pbound]
(i[PLtoIj) + [Ptot] + Kd
-1((i[PLtoj) + [Ptota] + Kd)2-(4i[P10t][PL10J)
2
where 1/i is the stoichiometry in moles of lipid monomer per mole of
protein, [PL,08] is the total phospholipid concentration, [P,0tal] is the total
concentration of pyr-Va, and Kd is the equilibrium dissociation constant.
An assumption made in this expression is that the SUVs contain multiple,
equivalent, non-interacting sites that may bind pyr-Va. The concentration
of bound pyr-V. was assumed to be related to the observed fluorescence
anisotropy of pyr-Va by [Pb)u.dI = [PtOt,IX(Arobs/Arsa2), where Arobs and
Arsat are the directly observed anisotropy changes at any added membrane
concentration and at saturation, respectively. For membranes of high acidic
lipid content, Ar8a2 was determined readily from the initial and saturating
fluorescence anisotropy values. For membranes of low acidic lipid content
(<15 mol % PS or 35 mol % DOPG), binding was weak, and values of
limiting anisotropy could not be clearly defmed experimentally. Therefore,
unique values of Kd and i could not always be determined for low-acidic-
lipid membranes (Koppaka and Lentz, 1996). For this reason, all three
parameters were determined from fitting globally at least two data sets to
the Langmuir model using Eq. 1 rearranged to express observed fluores-
cence anisotropy as a function of added lipid concentration (see Eq. 5 of
Koppaka and Lentz, 1996). In this analysis, we assigned the dissociation
constant Kd and stoichiometry of binding i as global variables and Ar.,
values as local variables (i.e., different and individually estimated for each
data set). Global analysis was done using SCoP, the Simulation Control
Program (Simulation Resources, Berrin Spring, MI). A multifit nonlinear
least-squares regression analysis constructed using the algorithms supplied
in the SCoP package was then used to vary Kd, i, and Arsat to fit to the
observed data.
Application of a two-process model for
protein binding
The binding isotherms were also fit to a model that assumes a simple,
general, two-process model for protein-membrane interactions (see Figure
Al in Lentz and Hermans, 1989). No temporal sequence is presumed in
this thermodynamic model. In one process, the protein is assumed to
adsorb to the membrane surface through an acidic-lipid-independent inter-
action. No assumptions are made as to the mechanism of this interaction,
although nonspecific electrostatic adsorption or partial hydrophobic pene-
tration are possibilities. The other component of the total interaction
involves the specific association of acidic lipids (or other special lipids)
with equivalent, non-interacting sites on the protein. Filling of these sites
is treated as governed by mass action, i.e., by the acidic lipid surface
concentration. The acidic lipids are assumed to behave roughly as a
two-dimensional ideal mixture with the neutral lipids, thus diffusing freely
in the two-dimensional space of the membrane surface. This is clearly an
approximation, as it ignores the finite size and structure of lipid polar head
regions as well as possible clustering or nonideality of lipid mixtures.
However, phase diagrams for mixtures of phosphatidylserine or phosphati-
dylglycerol with phosphatidylcholine indicate that these lipids mix reason-
ably ideally within the plane of SUV bilayers (Lentz et al., 1982; Tendian
and Lentz, 1990). A recent detailed study of nonideal mixing in PS/
phosphatidylcholine membranes confirms that demixing is minimal be-
tween species with similar acyl chains and at low (<40%) PS content
(Huang et al., 1993). Beyond the potential nonideality of lipid mixtures, the
model also ignores the finite size of the bound protein molecules and
possible interactions between bound proteins. Alterations in the model to
account for nonideal protein mixing in describing the membrane binding of
factor Va, prothrombin, or factor Xa added additional parameters but led to
descriptions of the data that were statistically not improved over the
simplest treatment (Cutsforth, 1991). In addition, the basic physical picture
was unchanged from that provided by the simple model used here
(Cutsforth, 1991). This simple form of the model has been used to describe
successfully the membrane binding of synthetic charged peptides (Kim et
al., 1991) and, with addition of Ca2+-binding sites, the binding of annexin
IV to PS-containing membranes (Junker and Creutz, 1994).
Within the context of this model, the observed binding constant for the
binding of protein to a membrane surface, Ka. obs may be written
Kaobs = K:(1 + kxf)m, (2)
where K: is the nonspecific binding affmiity (i.e., the binding affinity in the
absence of specific lipid-protein interactions), k is the acidic-lipid-specific,
site-binding constant for m equivalent sites on the protein, and Xf is the
mole fraction of free acidic lipid in the membrane. One other parameter is
required to describe membrane binding with this model, n, the maximal
number of protein molecules per lipid molecule that can fit on a membrane
surface.
Binding isotherms were simulated for fixed values of m, Ka, and k by
taking the total protein concentration as an initial estimate of free protein
concentration and the total acidic lipid mole fraction as an initial estimate
of Xf. Then, using equations A13 and A14 of Lentz and Hermans (1989),
the bound protein concentration and bound acidic lipid surface concentra-
tion were calculated and used to update the free protein concentration and
Xf. These were then used to recalculate the free protein and Xf. This
procedure was iteratively repeated until the change in Xf was <1 ppm
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0.17between iterations. Note that a typographical error exists in equation Al 3
of Lentz and Hermans (1989). The correct form is
0.16
[Pb_= Ka,obs[Pf][PL0][b] 3N12n(1 + Ka,obs[Pf]) 0.15
Once the calculation had converged for the lowest phospholipid concen-
tration in an isotherm, the binding equilibrium for the next higher phos-
pholipid concentration was modeled starting with an estimate for free
protein concentration equal to that obtained at the lower lipid concentration
and with an estimate of the Xf equal to the total acidic lipid concentration
in the membrane. This step-wise procedure was repeated until the entire
isotherm had been modeled. The summed squares of residuals between
calculated and observed bound protein concentrations was computed at the
end of each isotherm. This procedure was repeated in a grid search over
values of m, Ka, and k to obtain parameter values that gave the best fit of
the model to experiment.
RESULTS
General description of the binding isotherms
Examples of binding isotherms generated as described un-
der Materials and Methods are shown in Fig. 1. Panels A
and B show isotherms for binding of pyr-Va to PS-contain-
ing membranes, and panels C and D show isotherms for
binding to DOPG-containing membranes. The data are pre-
sented as the observed fluorescence anisotropy of pyrene-
labeled factor Va as a function of added membrane concen-
tration. Not surprisingly, binding was much weaker and
more difficult to saturate for membranes of low as com-
pared with high PS or DOPG content.
The total change in anisotropy observed at saturation
(Arsat) was estimated directly from titration data. Values
were consistent between duplicate or triplicate experiments
at high acidic lipid content but were less precisely deter-
mined at low acidic lipid content. Within experimental
uncertainty, values were independent of protein concentra-
tion and did not depend on the fluorescence spectrophotom-
eter used to record the data. Values varied as a function of
acidic lipid content, as shown in Fig. 2. The Arsat values
decreased with increasing DOPG content to a minimum at
25 mol % DOPG and then increased slowly with increasing
DOPG above this, approaching an asymptotic value of 0.04.
For PS-containing membranes, Arsat increased steadily from
5 mol % PS (the lowest PS content examined) to the same
asymptotic value of 0.04 at and above -12 mol % PS.
These data clearly support the contention that there is a
qualitative difference between the mechanisms of associa-
tion of pyr-Va to membranes of high and low acidic lipid
content, with the break in behavior occurring at roughly 12
mol % PS and 25 mol % DOPG. The very different values
of Arsat observed for pyr-Va bound to low-PS- and low-
DOPG-containing membranes also clearly indicate a differ-
ent behavior of pyr-Va bound to these two types of
membranes.
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FIGURE 1 Variation in pyrene fluorescence anisotropy as a measure of
binding of pyr-Va to (A) 5 mol % PS/POPC, (B) 30 mol % PS/POPC, (C)
10 mol % DOPG/POPC, and (D) 50 mol % DOPGIPOPC-containing
membranes. The pyr-Va fluorescence anisotropy values are plotted as a
function of concentration of added PS- and DOPG-containing membranes.
Lines represent binding isotherms predicted on the basis of the Langmuir
model with parameters summarized in Table 1.
Description of the data in terms of a Langmuir
adsorption model
Equilibrium dissociation constants (Kd) and stoichiometries
(I/i in units of lipids per bound protein) were determined as
described in Materials and Methods by fitting our binding
isotherms to a classical Langmuir adsorption model. To
overcome the indeterminacy of the binding model when
applied to weakly binding membranes (Koppaka and Lentz,
1996), we adjusted all three parameters (Kd, stoichiometry,
and Arsat) while fitting the Langmuir adsorption model
globally to at least two data sets obtained with membranes
having the same acidic lipid content but at different protein
concentrations. Stable parameter sets describing the data
were obtained by this procedure and are summarized in
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FIGURE 2 Saturating change in anisotropy of isotherms as a function of
anionic lipid content. Initial anisotropy values for pyr-V. in the absence of
lipid were subtracted from the saturating anisotropy values in the presence
of (A) PS-containing membranes or (B) DOPG-containing membranes.
Values estimated directly from the titration curves (0) represent the aver-
age of two to four experiments; error bars indicate the range (minimum/
maximum) of values observed. Dashed lines approach zero for POPC
membranes, as we could detect no change in fluorescence anisotropy even
for vesicle concentrations for which other measurements indicated that an
interaction with these membranes does occur (Koppaka and Lentz, 1995).
Values of Arsat obtained by globally fitting the data with Kd, i, and rsat as
local variables ([) are also given.
Table 1 and then displayed as a function of acidic lipid
content in Fig. 3. The lines drawn through the data shown in
Fig. 1 were calculated using the Langmuir adsorption model
and the best fit parameters given in Table 1. Limiting
anisotropy changes (Arsat) estimated by these curve-fitting
procedures are plotted versus membrane acidic lipid content
in Fig. 2. These Arsat values agreed well with estimates
made directly from titration curves except for membranes of
low acidic lipid content for which Arsat values estimated
experimentally were somewhat lower than those estimated
by fitting. Only for two experiments (10 mol % PS and 5
mol % DOPG) was there a significant difference between
these estimates of Arsat
TABLE I Empirical paramnetrs for binding of pyrene-V. to
PS- and DOPG-containing membranes
Membrane
composition Kd (nM) l/i
5/95 PS/POPC 7.04 ± 1.0 283 ± 59
8/92 PS/POPC 143.4 ± 0.6 106 ± 6
10/90 PS/POPC 51.3 ± 9.2 42 ± 10
12/88 PS/POPC 9.1 ± 1.3 73 ± 26
15/85 PS/POPC 2.3 ± 0.3 72 ± 5
25/75 PS/POPC 2.2 ± 0.4 42 ± 5
30/70 PS/POPC 2.6 ± 0.2 35 ± 2
40/60 PS/POPC 6.6 ± 1.0 19 ± 3
5/95 DOPG/POPC 422 ± 60 1116 ± 770
10/90 DOPG/POPC 332 ± 19 1064 ± 560
15/85 DOPG/POPC 1281 ± 21 63 ± 2
20/80 DOPG/POPC 662 ± 2 22 ± 2
25/5 DOPG/POPC 41.2 ± 14 40 ± 10
35/65 DOPG/POPC 7.9 ± 2.1 61 ± 17
50/50 DOPG/POPC 2.9 ± 0.4 77 ± 18
65/35 DOPG/POPC 1.1 ± 0.4 92 ± 28
Kd and stoichiometry values (lipids per binding site) were obtained by
adjusting both parameters so as to globally fit binding data (two or more
sets in each case) to Eq. 1, with Kd and i being global variables and the
values of Ar5,5 (best fit values shown in Fig. 2) as local variables. Global
fitting was accomplished using the ScOP simulation package (see Materi-
als and Methods), from which was obtained estimates of the standard
deviations in the best fit parameters.
Although uncertainty still exists in these binding param-
eters (especially the stoichiometry) at low acidic lipid con-
tent, there are two important observations that are clear
despite this uncertainty. The first and most remarkable is
that the parameter values seem to display very different
behaviors below and above 10-12 mol % PS and 15-25 mol
% DOPG. Kd values did not decrease monotonically with
acidic lipid content (Fig. 3 A). Rather, a maximum was
observed at low acidic lipid for both PS and DOPG, with the
Kd dropping dramatically and then changing very little at
higher acidic lipid content. A similar dramatic change takes
place in the stoichiometry parameter at the same acidic lipid
contents. We noted above a similar discontinuity in the Arsat
values for bound factor Va at 12 mol % PS and 25 mol %
DOPG. These observations suggest that the association of
factor Va with membranes may be somehow different above
and below 10-12 mol % PS or 15-25 mol % DOPG.
A second important observation is that the variations of
factor Va binding parameters with membrane acidic lipid
content are unlike the behavior of prothrombin and factor
X/Xa binding parameters, for which Kd decreased monoton-
ically with acidic lipid content (Cutsforth et al., 1989). This
is the behavior to be expected when binding is dominated by
association of a few acidic lipid molecules to a limited
number of sites on the protein (Cutsforth et al., 1989). That
this simple model may not apply to the binding of factor Va
is argued by the fact that the variation of Kd with acidic lipid
content is so dramatically different from that seen with
prothrombin or factor Xa.
w X w * w
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FIGURE 3 (A) Variation of empirical dissociation constants with acidic
lipid content. Values for DOPG vesicles (-) or PS vesicles (0) were
obtained by global fitting of at least two independent titrations performed
at different total protein concentrations (see Materials and Methods). (B)
Acidic lipid dependence of the apparent binding stoichiometry. Stoichiom-
etry values (phospholipids per bound protein) for PS-containing (0) and
DOPG-containing (0) membranes were determined as in A.
Application of a simple two-process model for
extrinsic protein binding
To contrast more precisely the membrane binding of factor
Va with that of prothrombin and factor X/Xa, the simple
two-process binding model described by Lentz and Her-
mans (1989) was applied to the binding of pyr-Va. Appli-
cation of this binding model involves the evaluation of four
parameters: m, n, Ka, and k (see Materials and Methods for
more detail). The maximal number of bound protein mole-
cules per phospholipid molecule, n, was fixed based on the
experimentally determined minimal or asymptotic number
of phospholipids per bound factor Va molecule (see Fig. 3
B). For PS-containing membranes, n = 0.0526 proteins per
phospholipid was used; for DOPG-containing membranes,
n was fixed at 0.018 proteins per phospholipid. It is worth
commenting that the number of phospholipids needed to
accommodate one molecule of factor Va on PS-containing
membranes (19-20; derived from data obtained with 40 mol
% PS membranes; see Fig. 3 B) was surprisingly low, as
other, lower molecular weight coagulation proteins appear
to require much larger numbers of phospholipids per bound
protein (40 for factor X/Xa or 50 for prothrombin; Cutsforth
et al., 1989). We note that attempts to fit the data for binding
to PS-containing membranes with smaller values of n
(greater numbers of phospholipids per bound protein) gen-
erated measurably poorer fits. A recent attempt at defining
the structure of membrane-bound factor Va (Stoylova et al.,
1994) estimates that the membrane-contacting region of
factor Va is quite small and covers only approximately 10
phospholipids in the outer leaflet of a PS-rich membrane,
consistent with our observations and with the value of n we
used.
Parameter values for m, K:, and k were determined by a
grid search to minimize the sum of squared residuals.
Briefly, a range of values for each of the parameters was
defined and a grid was designed to test all combinations of
the parameters. The value for m was fixed and systemati-
cally varied from 1 to 20. For each integer value of m, the
values for Ka and k were varied to determine the best fit
parameter values. For both PS- and DOPG-containing
membrane data sets, m = 3 provided the best fit to the data
(lowest sum of squared residuals). Large values of m (>6-
10) were not tenable. This small value of m argues against
a lipid pool or lipid domain binding model, as discussed
below.
With the value for m fixed at 3, K: and k were varied to
optimize globally the fit of all the calculated isotherms to all
the experimental data (fits not shown). Although the iso-
therms could be fit adequately for either the PS membranes,
the low DOPG membranes, or the high DOPG-containing
membranes, it was not possible to obtain an adequate fit of
all the data with a single set of parameters. Attempts to fit
individual isotherms further supported the conclusion that it
would be impossible to obtain a global fit of all the iso-
therms with the same set of parameters. Fits to PS mem-
brane isotherms could be obtained with a narrow range of
values for the nonspecific association constant (K: = 2200
to 2500 M-1), but for DOPG membranes very different
values were needed (4500-5500 M 1 for 5, 15, and 20 mol
% DOPG membranes and 3700 M- 1 for >20 mol % DOPG
membranes). In addition, the specific site affinity constants
had to be increased with acidic lipid content to optimize the
fits of calculated isotherms to individual experimental iso-
therms (see Table 2). Fig. 4 shows the fits of the simulated
curves generated by the parameters given in Table 2 to
semi-logarithmic plots of the data. The failure of the model,
under near saturating conditions, for low-acidic-lipid-con-
taining membranes seems to reflect uncertainty in the pa-
rameter Arsat, as discussed in reference to Fig. 2. As k and
K: are determined mainly by the rising portion of the
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TABLE 2 Parameter vales used to obtain a best fit of simulations to semilogarlthmic isothenms
Lipid m* Stoichiometryt ka§ K: (M-')* s2 x2
8% PS 3 19 26 (18-35) 2200 (800-5400) 1.8 x 10-l6, 0.72
10% PS 3 19 28 (17-46) 2200(1800-3900) 3.2 x 10-16, 1.26
>10% PS 3 19 40(30-55) 2500(1800-3900) 0.6 x 10-16, 0.22
<20% DOPG 3 60 3 (0-6) 5000(3000-7600) 1.6 x 10-16, 0.6
20% DOPG 3 60 8 (4-10) 4500(3200-6700) 6.2 x 10-'7, 0.23
>20% DOPG 3 60 16 (10-30) 3700(2500-8100) 5.5 x 10-17, 0.21
*Only integer values were considered. Small values ofm (2-5) all gave comparable values of S2 in a grid search for optimal parameters (see Materials and
Methods); m = 3 gave slightly lower values of s2.
tFixed according to minimal values of the stoichiometry obtained from fitting isotherms to a classical surface adsorption model (Table 1). Values given
have units of phospholipids per bound protein, i.e., l/n.
*The uncertainty ranges of k and K: were defined by values that resulted in an increase in S2 by a factor of two relative to the minimized s2.
tThe variance of the fit (s2) was calculated as the mean square deviation of the calculated from the observed concentration of bound protein divided by
the number of degrees of freedom for the data set.
IlThe reduced x2 of the fit is defined as s2/(Ca), where (af) is the mean square standard deviation of all points in a data set. This was estimated from
uncertainties in anisotropy measurements. The reduced x2 is a measure of goodness of fit; a value close to 1 theoretically indicates that the model provides
a good description of the data (Bevington, 1969). A value less than 1 can mean that the errors associated with individual data points were overestimated.
binding isotherms, this uncertainty in Arsat should not affect
our overall conclusions.
DISCUSSION
Difficulties in defining the mechanism of factor Va
binding to membranes
The mechanism by which factor Va binds to acidic lipid
membranes is a matter of controversy. The acidic lipid
requirement for binding as well as the ionic strength depen-
dence of the binding has led to the proposal that binding
may occur via an electrostatic adsorption mechanism (Pusey
et al., 1982; Pusey and Nelsestuen, 1984), with little if any
penetration of the bilayer (Mayer et al., 1983). However,
there is disagreement over this issue and even over whether
binding is indeed ionic strength dependent (Bloom et al.,
1979; Higgins and Mann, 1983). Thus, some have sug-
gested that factor Va binding is not electrostatic in nature
but may involve hydrophobic penetration into the contacted
monolayer (Lecompte et al., 1987, 1994; Kalafatis et al.,
1990). Others suggest that both types of interaction, elec-
trostatic and hydrophobic, are present (Pusey et al., 1982)
but occur in different regions of the factor Va light chain
(Kalafatis et al., 1994) involved in factor Va binding.
In addition to disagreement as to the binding mechanism,
there is also controversy about the nature of the acidic-lipid-
binding site for factor Va. The condensation of the pro-
thrombinase complex on an acidic lipid membrane has often
been discussed in terms of existence of acidic-lipid-rich
binding sites on the membrane surface. This acidic lipid
domain model was originally proposed for cytochrome c
binding to mixed cardiolipin/spin-labeled cholesterol mem-
branes (Birrell and Griffith, 1976) and then applied to the
binding of several extrinsic proteins, including prothrombin
(Lim et al., 1977; Mayer and Nelsestuen, 1981) and factors
Xa and Va (Bloom et al., 1979; Mayer and Nelsestuen, 1981,
1983; Pusey et al., 1982). The domain or cluster model of
extrinsic protein interaction has been questioned even for
cytochrome c (Reitveld et al., 1986) and has also been
challenged with regard to the prothrombinase components
(Lentz et al., 1985; Jones and Lentz, 1986; van de Waart et
al., 1987; Tendian and Lentz, 1990; Bazzi and Nelsestuen,
1991).
One reason for the controversies over binding mechanism
has been the difficulty associated with measuring factor Va
binding to membranes. The problems in evaluating factor
Va binding have been, first, in obtaining an adequate protein
preparation and, second, in identifying a detection system
sensitive enough to report incomplete binding for such a
tightly bound protein. The development and application of a
pyrene-labeled, antibody-purified bovine factor Va mole-
cule by Krishnaswamy and Mann (1988) has provided a
methodology of sufficient sensitivity to resolve the tight
binding of an immunopurified factor Va preparation. The
fluorescent signal is sensitive to binding at submicromolar
concentrations of pyr-V., and the anisotropy change is sat-
urable upon association of the protein molecules with the
membrane surface. It is worth noting that dissociation con-
stants obtained using the labeled factor Va agree with dis-
sociation constants obtained as the ratio of off to on rate
constants obtained using light-scattering techniques (Krish-
naswamy et al., 1988).
Insights into the factor Va binding mechanism
Our results with pyrene-labeled factor Va extend the work
of Krishnaswamy and Mann (1988) and provide five new
insights into the binding of factor Va to acidic-lipid-con-
taining membranes: 1) behavior depends on membrane
acidic lipid content, 2) behavior is different for PS- versus
DOPG-containing membranes, 3) two types of interactions
are involved, 4) a small number of acidic lipids are in-
volved, and 5) binding appears to cause acidic-lipid-depen-
dent conformational changes in factor Va. First, the essential
difference between the interaction of factor Va with acidic-
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Fig. 3, very different empirical
obtained in these two regimes,
then little variation with increasii
contrasts with the monotonic di
high acidic lipid content for p
binding (Cutsforth et al., 1989)
providing description by the t,%
differed according to acidic lipid
the observed values of Arsat wer
to membranes of low and high a
Not only must the binding be di
nature of the bound protein also
X I membranes that are either poor or rich in acidic lipids. This
dependence on acidic lipid content correlates with the dif-
ference in kcat for prothrombin activation by prothrombinase
0 assembled on PS- or DOPG-rich versus PS- or DOPG-poor
membranes (Pei et al., 1993).
Second, it is evident from our results that binding of
factor Va was qualitatively different for the two species of
acidic lipids employed in these studies. We have chosen to
contrast binding to membranes containing PS and DOPG, as
these two acidic lipids will produce membranes with very
similar surface potentials (Winiski et al., 1986) that none-
theless support prothrombinase complexes with very differ-
ent activities (Pei et al., 1993). The apparent dissociation
constants for binding to PS-containing membranes were
l l between 3.5- and 78-fold lower than for binding to mem-
branes containing comparable surface concentrations of
DOPG. The difference was greatest for 15 mol % and
decreased at high and low acidic lipid surface concentra-
V ;t / tions. A paper that appeared since this work was completed
reports that the binding of factor Va is 25-fold tighter to
&Zo/ PS-containing membranes prepared from the natural L-ste-
v f2nY reoisomer rather than the D-stereoisomer (Comfurius et aL,
1994). It is unclear at this point whether this specificity in
factor Va binding can account for the PS specificity we have
recorded for activation of prothrombin by the assembled
prothrombinase (Pei et al., 1993) as both factor Xa binding
(Cutsforth et al., 1989) and prothrombin structural changes
also show PS specificity (Lentz et al., 1991; Wu and Lentz,
1991).
1 0 100 1000 A third insight offered by analysis of our data in terms of
the two-process binding model is that two types of interac-
ncentration (i.sM) tions seem necessary to describe the membrane binding of
factor Va. In contrast to prothrombin and factor X/Xa bind-
sotherms of pyr-Va to (A) PS- and ing, for which the acidic-lipid-independent surface adsorp-
5, 8mol % PS;E,30 mol% PS; tion constant (Ka) was insignificant (1 M-l; Cutsforth et al.,
)r 5 mol % PS membranes but are 1989), the values of this constant needed to describe factor
8 mol % PS data. (B) 0, 5 mol % Va binding are substantial (Table 2). This prediction of a
I % DOPG;V, 35 mol % DOPG; significant acidic-lipid-independent interaction is supported
?G. The ability of the two-process by our observation by four different measurements of factor
sotherms is demonstrated by the
usighealesumariedin Va binding to neutral membranes (Koppaka and Lentz,using the values summanized in a1996). Binding to neutral membranes appears to occur with
a Kd of roughly 3.0 ,M and stoichiometry of approximately
200 lipids per site (Koppaka and Lentz, 1996). This inter-
or membranes is evident action is stronger than the acidic-lipid-independent interac-
our results. As indicated by tion observed with PS- or DOPG-containing membranes
I binding parameters were (Ka in Table 2). This means that the acidic-lipid-indepen-
with a dramatic drop and dent interaction predicted by our two-process binding model
ng acidic lipid content. This is not truly independent of acidic lipid content but is stron-
ecrease of Kd from low to ger for neutral than for charged membranes. In fact, K:
)rothrombin and factor Xa decreased as acidic lipid content increased, a situation illus-
. Similarly, the parameters trated most dramatically by the binding to DOPG-contain-
vo-site binding model also ing membranes (Table 2). This linkage between k and K:
I content (Table 2). Finally, violates one of the assumptions made in our two-process
e very different for binding binding model as applied to factor Va binding and therefore
cidic lipid content (Fig. 2). forces us to conclude that the membrane-binding mecha-
escribed differently but the nism of factor Va may be more complex than the simple,
appears to be different for two-process, independent-site, binding mechanism that is
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capable of describing the membrane binding of prothrombin
and factor X/Xa.
Our data do not address the nature of the acidic-lipid-
independent interaction. It could be hydrophobic or electro-
static in nature. In either case, the strength of the interaction
appears to depend on the chemical nature of acidic lipids in
the membrane (Table 2). As membranes containing compa-
rable surface concentrations of PS and DOPG have compa-
rable surface potentials (Winiski et al., 1986), the observed
species specificity of K: means that acidic-lipid-indepen-
dent binding is not likely to occur by adsorption to a
diffusely charged surface. Also, if K° were due solely to
electrostatic attraction, it should increase with acidic lipid
content rather than decrease or remain constant as observed
(Table 2). At this point, we speculate, on the basis of other
reports (Kalafatis et al., 1990, 1994; Lecompte et al., 1987,
1994), that the acidic-lipid-independent interaction is hy-
drophobic in nature.
The fourth insight offered by our results is that factor Va
binding is not likely to occur by a nonspecific electrostatic
adsorption to a pool or domain of acidic lipids. This is based
on the observation of acidic lipid specificity, as discussed
above, and on the value of m required to fit the data. For
both types of membranes examined, the assumption of the
existence of three such sites (m = 3) provided the best fit to
our data. The assumption of an acidic lipid cluster (m = 10
or greater) as a binding site could not provide a fit to our
data because it results in a more dramatic decrease in Kd
with acidic lipid content than observed.
The fifth and most intriguing insight offered by our
results is that membrane binding of factor Va appears to
alter the protein in a significant way, perhaps via protein
conformational changes induced by binding of acidic lipids
to specific sites on the protein. This derives primarily from
the variation of the saturating anisotropy change, Arsat, with
acidic lipid content (see Fig. 2).
There are three effects that can account for the observed
shift in the value of Arsat. First, there should be an increase
in anisotropy due to decreased rotational freedom of the
whole factor Va molecule when bound to a membrane. This
effect is evidenced by a changed slope of a Perrin plot
(Lakowicz, 1983). Second, there may be a change in the
intrinsic anisotropy (ro) of the pyrene probe bound to the
free protein versus bound to the membrane-bound protein.
This would have to arise from a change in the electronic
distribution within pyrene in these two states and so this
effect should be insignificant. The third effect reflected in
Arrsat will be a change in the local or segmental motion of
the probe attached to the protein. This effect is revealed in
the limiting or apparent rO (ro app) obtained from measure-
ments extrapolated to infinite viscosity by means of a Perrin
plot (Lakowicz, 1983). This contribution would reflect a
change in the local (i.e., in the region of the probe) dynam-
ics of the protein in the membrane-bound versus free state.
As Perrin plots for free and membrane-bound (25% PS)
pyr-Va were nearly parallel (Krishnaswamy and Mann,
membrane binding is to effect a substantial change in ro,app.
This is verified by comparing Arsat (0-038) to ArO,app
(0.034) obtained from the Perrin plot (Krishnaswamy and
Mann, 1988). We conclude that the variation in Arsat values
with PS or DOPG membrane content probably reflects a
change in the local dynamics of pyr-Va bound to mem-
branes rich in these lipids as compared with membranes
with low acidic lipid content.
The Arsat values, to a first approximation, follow two
behaviors. For membranes of high acidic lipid content, Arrsat
was reasonably invariant or approached a limiting value of
roughly 0.04. For membranes of lower acidic lipid content,
however, Arsat varied substantially with changes in acidic
lipid content. This indicates that the conformational state of
pyr-Va was quite different when bound to acidic-lipid-poor
membranes as compared with the conformational state on
acidic-lipid-rich membranes. This shift in conformation
could reflect the effect of surface charge or could result
from binding of acidic lipids to specific acidic lipid sites on
the protein. Given the very different effects of PS and
DOPG membranes, which have comparable surface poten-
tials (Winiski et al., 1986), we prefer the latter interpreta-
tion. This argues in favor of changes in protein dynamics or
conformation being triggered by occupancy of acidic-lipid-
specific sites on the protein. An acidic-lipid-induced protein
conformational change would be consistent with the obser-
vation that the acidic-lipid site binding constants (k values)
and acidic-lipid-independent binding constants (Ka) derived
from the two-process model varied with acidic lipid species
and acidic lipid membrane content (Table 2). We suggest
that occupancy of acidic-lipid-binding sites alters the con-
figuration of the protein such that both the acidic lipid sites
and the acidic-lipid-independent interaction are altered.
A model for factor Va-membrane association
Although our data and analysis do not provide sufficient
information to define the mechanism of factor Va binding,
they do suggest some insights that can be summarized in
terms of a model that is at least consistent with available
data (see Fig. 5). We propose that factor Va interacts with
PS- or DOPG-containing membranes by both acidic-lipid-
dependent and acidic-lipid-independent mechanisms. Our
current bias is that the acidic-lipid-independent binding is
hydrophobic in nature. The existence of two types of inter-
actions presumably involving at least two sites on factor Va
is consistent with the fact that a membrane-associated pho-
toactivatable reagent labels two regions of factor Va light
chain (Kalafatis et al., 1994). We propose further that a
small number of acidic-lipid-specific sites on factor Va can
account for the acidic-lipid-dependent interaction. Occu-
pancy of these sites seems also to induce a substantial
change in the conformation or molecular dynamics of mem-
brane-bound factor Va, which, in turn, alters the affinity of
these sites and the strength of the acidic-lipid-independent
1988), this clearly indicates that the major influence of
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FIGURE 5 A proposed model for the binding of factor Va to a membrane surface. This model summarizes the features of factor Va binding that have
been revealed by the analysis presented here as follows: 1) binding behavior depends on membrane acidic lipid content, 2) behavior is different for PS-
versus DOPG-containing membranes, 3) two types of factor Va-membrane interactions are involved, 4) a small number of acidic lipids are involved, and
5) binding appears to cause acidic-lipid-dependent conformational changes in factor Va. The first type of interaction is an acidic-lipid-independent
adsorption, which for factor Va is significant and is represented by hydrophobic penetration, although our data cannot demonstrate this mechanism. The
second type of interaction involves binding of negatively charged lipid molecules in the membrane to a few discrete sites on the protein. There is no
significance to the order in which these steps are represented in the drawing. Acidic-lipid-induced changes in the dynamics or conformation of factor Va
implied by our results are illustrated as changes in the shape of the molecule.
lipid implied by this picture suggests that factor Va binding
might better be viewed as formation of a protein-lipid
complex rather than as a simple surface binding phenome-
non.
This model implies that factor Va exists in different
bound forms depending on the occupancy of its acidic-lipid-
binding sites. On DOPG-containing or PS-poor membranes,
factor Va would be expected to exist in a form that covers a
large number of phospholipids, whereas, on PS-rich mem-
branes, it might exist in a form that extends from the
membrane surface and covers only a small number of phos-
pholipids. Such a picture would be consistent with appar-
ently conflicting reports offering evidence in favor of both
types of structures (Pusey et al., 1982; Lampe et al., 1984;
Isaacs et al., 1986; Stoylova et al., 1994). Such a confor-
mational equilibrium might also be influenced by interac-
tion with other components of the prothrombinase complex,
an interesting possibility that will have to be tested inde-
pendently as more evidence is sought to test this picture.
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